Brazil vs Uganda: The number of people with susceptibility test result for rifampicin
Brazil
24,394
in 2021
Uganda
28,418
in 2021
Brazil rank
14th
Uganda rank
11th
The number of people with susceptibility test result for rifampicin over time
- Brazil
- Uganda
How they compare
Uganda currently reports 28,418 against 24,394 in Brazil, a difference of 4,024.
That makes Uganda's figure about 1.2 times Brazil's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Uganda ahead.
Brazil ranks 14th and Uganda ranks 11th of 155 countries.
Across the 2 decades both report, Brazil averaged higher in 1 and Uganda in 1.
Head to head by decade
| Decade | Brazil | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20,251 | 23,037 | 2,786 | Uganda |
| 2020s | 24,076 | 23,910 | 167 | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brazil or Uganda?
- Uganda, at 28,418 against 24,394 in Brazil as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brazil and Uganda?
- 4,024, with Uganda ahead.
- How many years of comparable data are there for Brazil and Uganda?
- 5 years are reported by both, from 2017 to 2021.
- How do Brazil and Uganda rank globally for the number of people with susceptibility test result for rifampicin?
- Brazil ranks 14th and Uganda ranks 11th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.